MBI - MBIA Inc

https://www.mbia.com

Strong Sell Momentum: Bearish

Recent News

Oscar Health ( OSCR ) Soars 7.8%: Is Further Upside Left in the Stock?

Zacks Commentary • 2 months, 4 weeks ago • score: -0.08

Oscar Health (OSCR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Neutral

MBIA ( MBI ) Reports Q1 Loss, Tops Revenue Estimates

Zacks Commentary • 4 months ago • score: -0.01

MBIA (MBI) delivered earnings and revenue surprises of -128.57% and 28.57%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Bullish

Down -29.5% in 4 Weeks, Here's Why You Should You Buy the Dip in MBIA ( MBI )

Zacks Commentary • 5 months, 2 weeks ago • score: 0.25

MBIA (MBI) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Neutral

MBIA ( MBI ) Reports Q4 Loss, Tops Revenue Estimates

Zacks Commentary • 6 months, 2 weeks ago • score: 0.14

MBIA (MBI) delivered earnings and revenue surprises of -336.36% and 31.82%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Neutral

MBIA ( MBI ) Soars 15.4%: Is Further Upside Left in the Stock?

Zacks Commentary • 7 months, 1 week ago • score: 0.08

MBIA (MBI) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Range-Bound

As of 2025-09-10 (Snapshot)

MBIA Inc. provides financial insurance services to the public financial markets. The company is headquartered in Purchase, New York.

52W High

$8.26

52W Low

$3.22

MA Status:

50D: Above 200D: Above

Beta (~1 neutral, <0.9 lower risk)

1.66

Valuation

Rich

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

86.96

EV/EBITDA (<8 favorable)

N/A

EV/Revenue (<3 favorable)

34.08

P/S (TTM) (<3 favorable)

3.49

P/B (<3 favorable)

3.53

Ownership

Balanced

Source: Overview

Insiders (1–5% typical)

10.43%

Institutions (25–75% balanced)

46.40%

Shares Outstanding

50,489,000

Float

43,900,500

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

2023-12-15

Income & Growth

As of 2025-06-30 (Overview)

Revenue (TTM)

108,000,000

Gross Profit (TTM)

64,000,000

EPS (TTM)

-4.51

Profit Margin (>10% good)

-2.08%

Operating Margin (TTM) (higher better)

0.06%

ROE (TTM) (>15% strong)

N/A

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

0.91

Momentum

Bearish momentum

Value

0.6995

0.7808

Trend

Falling

Signal Cross

No cross

As of

Sep. 05, 2025